These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37676146)

  • 1. A standardised protocol for relative SARS-CoV-2 variant severity assessment, applied to Omicron BA.1 and Delta in six European countries, October 2021 to February 2022.
    Nyberg T; Bager P; Svalgaard IB; Bejko D; Bundle N; Evans J; Krause TG; McMenamin J; Mossong J; Mutch H; Omokanye A; Peralta-Santos A; Pinto-Leite P; Starrfelt J; Thelwall S; Veneti L; Whittaker R; Wood J; Pebody R; Presanis AM
    Euro Surveill; 2023 Sep; 28(36):. PubMed ID: 37676146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron variants of SARS-CoV-2.
    Ward T; Glaser A; Overton CE; Carpenter B; Gent N; Seale AC
    Epidemiol Infect; 2022 Dec; 151():e32. PubMed ID: 36535802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.
    Nyberg T; Ferguson NM; Nash SG; Webster HH; Flaxman S; Andrews N; Hinsley W; Bernal JL; Kall M; Bhatt S; Blomquist P; Zaidi A; Volz E; Aziz NA; Harman K; Funk S; Abbott S; ; Hope R; Charlett A; Chand M; Ghani AC; Seaman SR; Dabrera G; De Angelis D; Presanis AM; Thelwall S
    Lancet; 2022 Apr; 399(10332):1303-1312. PubMed ID: 35305296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England.
    Strasser ZH; Greifer N; Hadavand A; Murphy SN; Estiri H
    JAMA Netw Open; 2022 Oct; 5(10):e2238354. PubMed ID: 36282501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in Southern California.
    Lewnard JA; Hong VX; Patel MM; Kahn R; Lipsitch M; Tartof SY
    Nat Med; 2022 Sep; 28(9):1933-1943. PubMed ID: 35675841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes and phylogenetic analysis in reflection with three predominant clades of SARS-CoV-2 variants.
    Ali KM; Rashid PMA; Ali AM; Tofiq AM; Salih GF; Dana OI; Rostam HM
    Eur J Clin Invest; 2023 Sep; 53(9):e14004. PubMed ID: 37036255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Risk of Hospitalization and Severe Disease Among Co-circulating Severe Acute Respiratory Syndrome Coronavirus 2 Variants.
    Trobajo-Sanmartín C; Miqueleiz A; Guevara M; Fernández-Huerta M; Burgui C; Casado I; Baigorria F; Navascués A; Ezpeleta C; Castilla J
    J Infect Dis; 2023 Feb; 227(3):332-338. PubMed ID: 36179126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
    Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN
    Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severity and outcomes of Omicron variant of SARS-CoV-2 compared to Delta variant and severity of Omicron sublineages: a systematic review and metanalysis.
    Relan P; Motaze NV; Kothari K; Askie L; Le Polain O; Van Kerkhove MD; Diaz J; Tirupakuzhi Vijayaraghavan BK
    BMJ Glob Health; 2023 Jul; 8(7):. PubMed ID: 37419502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
    Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
    PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of SARS-CoV-2 variants of concern over a period of Delta and Omicron cocirculation, among patients hospitalized for COVID-19 in an Italian reference hospital: Impact on clinical outcomes.
    Mondi A; Mastrorosa I; Piselli P; Cimaglia C; Matusali G; Carletti F; Giannico G; Milozzi E; Biliotti E; Di Bari S; Chinello P; Beccacece A; Faraglia F; Vittozzi P; Mosti S; Tetaj N; Stazi GV; Pinnetti C; Camici M; D'Annunzio A; Marani A; Fabeni L; Specchiarello E; Gruber CEM; Villanacci A; Minicucci S; Garbuglia AR; Ianniello S; Marchioni L; Taglietti F; D'Offizi G; Palmieri F; Nicastri E; Maggi F; Vaia F; Girardi E; Antinori A
    J Med Virol; 2023 Jun; 95(6):e28831. PubMed ID: 37246793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline Sequencing Surveillance of Public Clinical Testing, Hospitals, and Community Wastewater Reveals Rapid Emergence of SARS-CoV-2 Omicron Variant of Concern in Arizona, USA.
    Smith MF; Holland SC; Lee MB; Hu JC; Pham NC; Sullins RA; Holland LA; Mu T; Thomas AW; Fitch R; Driver EM; Halden RU; Villegas-Gold M; Sanders S; Krauss JL; Nordstrom L; Mulrow M; White M; Murugan V; Lim ES
    mBio; 2023 Feb; 14(1):e0310122. PubMed ID: 36622143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing changes in incubation period, serial interval, and generation time of SARS-CoV-2 variants of concern: a systematic review and meta-analysis.
    Xu X; Wu Y; Kummer AG; Zhao Y; Hu Z; Wang Y; Liu H; Ajelli M; Yu H
    BMC Med; 2023 Sep; 21(1):374. PubMed ID: 37775772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcomes after SARS-CoV-2 infection in periods dominated by delta and omicron variants in Scotland: a population-based cohort study.
    Stock SJ; Moore E; Calvert C; Carruthers J; Denny C; Donaghy J; Hillman S; Hopcroft LEM; Hopkins L; Goulding A; Lindsay L; McLaughlin T; Taylor B; Auyeung B; Katikireddi SV; McCowan C; Ritchie LD; Rudan I; Simpson CR; Robertson C; Sheikh A; Wood R
    Lancet Respir Med; 2022 Dec; 10(12):1129-1136. PubMed ID: 36216011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study.
    Bager P; Wohlfahrt J; Bhatt S; Stegger M; Legarth R; Møller CH; Skov RL; Valentiner-Branth P; Voldstedlund M; Fischer TK; Simonsen L; Kirkby NS; Thomsen MK; Spiess K; Marving E; Larsen NB; Lillebaek T; Ullum H; Mølbak K; Krause TG;
    Lancet Infect Dis; 2022 Jul; 22(7):967-976. PubMed ID: 35468331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Directions of change in intrinsic case severity across successive SARS-CoV-2 variant waves have been inconsistent.
    Pascall DJ; Vink E; Blacow R; Bulteel N; Campbell A; Campbell R; Clifford S; Davis C; da Silva Filipe A; El Sakka N; Fjodorova L; Forrest R; Goldstein E; Gunson R; Haughney J; Holden MTG; Honour P; Hughes J; James E; Lewis T; MacLean O; McHugh M; Mollett G; Nyberg T; Onishi Y; Parcell B; Ray S; Robertson DL; Seaman SR; Shabaan S; Shepherd JG; Smollett K; Templeton K; Wastnedge E; Wilkie C; Williams T; ; Thomson EC
    J Infect; 2023 Aug; 87(2):128-135. PubMed ID: 37270070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and Clinical Epidemiology of SARS-CoV-2 Infection among Vaccinated and Unvaccinated Individuals in a Large Healthcare Organization from New Jersey.
    Mediavilla JR; Lozy T; Lee A; Kim J; Kan VW; Titova E; Amin A; Zody MC; Corvelo A; Oschwald DM; Baldwin A; Fennessey S; Zuckerman JM; Kirn T; Chen L; Zhao Y; Chow KF; Maniatis T; Perlin DS; Kreiswirth BN
    Viruses; 2023 Aug; 15(8):. PubMed ID: 37632041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.
    Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimated BNT162b2 Vaccine Effectiveness Against Infection With Delta and Omicron Variants Among US Children 5 to 11 Years of Age.
    Khan FL; Nguyen JL; Singh TG; Puzniak LA; Wiemken TL; Schrecker JP; Taitel MS; Zamparo JM; Jodar L; McLaughlin JM
    JAMA Netw Open; 2022 Dec; 5(12):e2246915. PubMed ID: 36515946
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.